1
|
Ponthier JL, Schluepen C, Chen W, Lersch RA, Gee SL, Hou VC, Lo AJ, Short SA, Chasis JA, Winkelmann JC, Conboy JG. Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16. J Biol Chem 2006; 281:12468-74. [PMID: 16537540 DOI: 10.1074/jbc.m511556200] [Citation(s) in RCA: 90] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Activation of protein 4.1R exon 16 (E16) inclusion during erythropoiesis represents a physiologically important splicing switch that increases 4.1R affinity for spectrin and actin. Previous studies showed that negative regulation of E16 splicing is mediated by the binding of heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins to silencer elements in the exon and that down-regulation of hnRNP A/B proteins in erythroblasts leads to activation of E16 inclusion. This article demonstrates that positive regulation of E16 splicing can be mediated by Fox-2 or Fox-1, two closely related splicing factors that possess identical RNA recognition motifs. SELEX experiments with human Fox-1 revealed highly selective binding to the hexamer UGCAUG. Both Fox-1 and Fox-2 were able to bind the conserved UGCAUG elements in the proximal intron downstream of E16, and both could activate E16 splicing in HeLa cell co-transfection assays in a UGCAUG-dependent manner. Conversely, knockdown of Fox-2 expression, achieved with two different siRNA sequences resulted in decreased E16 splicing. Moreover, immunoblot experiments demonstrate mouse erythroblasts express Fox-2. These findings suggest that Fox-2 is a physiological activator of E16 splicing in differentiating erythroid cells in vivo. Recent experiments show that UGCAUG is present in the proximal intron sequence of many tissue-specific alternative exons, and we propose that the Fox family of splicing enhancers plays an important role in alternative splicing switches during differentiation in metazoan organisms.
Collapse
Affiliation(s)
- Julie L Ponthier
- Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Hou VC, Lersch R, Gee SL, Ponthier JL, Lo AJ, Wu M, Turck CW, Koury M, Krainer AR, Mayeda A, Conboy JG. Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. EMBO J 2002; 21:6195-204. [PMID: 12426391 PMCID: PMC137214 DOI: 10.1093/emboj/cdf625] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
A physiologically important alternative pre-mRNA splicing switch, involving activation of protein 4.1R exon 16 (E16) splicing, is required for the establishment of proper mechanical integrity of the erythrocyte membrane during erythropoiesis. Here we identify a conserved exonic splicing silencer element (CE(16)) in E16 that interacts with hnRNP A/B proteins and plays a role in repression of E16 splicing during early erythropoiesis. Experiments with model pre-mRNAs showed that CE(16) can repress splicing of upstream introns, and that mutagenesis or replacement of CE(16) can relieve this inhibition. An affinity selection assay with biotinylated CE(16) RNA demonstrated specific binding of hnRNP A/B proteins. Depletion of hnRNP A/B proteins from nuclear extract significantly increased E16 inclusion, while repletion with recombinant hnRNP A/B restored E16 silencing. Most importantly, differentiating mouse erythroblasts exhibited a stage-specific activation of the E16 splicing switch in concert with a dramatic and specific down-regulation of hnRNP A/B protein expression. These findings demonstrate that natural developmental changes in hnRNP A/B proteins can effect physiologically important switches in pre-mRNA splicing.
Collapse
Affiliation(s)
| | | | | | | | | | - Michael Wu
- Lawrence Berkeley National Laboratory, Life Sciences Division and
Department of Molecular and Cellular Biology, University of California at Berkeley, Berkeley, CA 94720, University of California, San Francisco, HHMI, Department of Medicine and Cardiovascular Research Institute, San Francisco, CA 94143, Department of Medicine, Vanderbilt University, Veterans Affairs Medical Centers, Nashville, TN 37232, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 and University of Miami School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA Corresponding author e-mail:
| | - Chris W. Turck
- Lawrence Berkeley National Laboratory, Life Sciences Division and
Department of Molecular and Cellular Biology, University of California at Berkeley, Berkeley, CA 94720, University of California, San Francisco, HHMI, Department of Medicine and Cardiovascular Research Institute, San Francisco, CA 94143, Department of Medicine, Vanderbilt University, Veterans Affairs Medical Centers, Nashville, TN 37232, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 and University of Miami School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA Corresponding author e-mail:
| | - Mark Koury
- Lawrence Berkeley National Laboratory, Life Sciences Division and
Department of Molecular and Cellular Biology, University of California at Berkeley, Berkeley, CA 94720, University of California, San Francisco, HHMI, Department of Medicine and Cardiovascular Research Institute, San Francisco, CA 94143, Department of Medicine, Vanderbilt University, Veterans Affairs Medical Centers, Nashville, TN 37232, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 and University of Miami School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA Corresponding author e-mail:
| | - Adrian R. Krainer
- Lawrence Berkeley National Laboratory, Life Sciences Division and
Department of Molecular and Cellular Biology, University of California at Berkeley, Berkeley, CA 94720, University of California, San Francisco, HHMI, Department of Medicine and Cardiovascular Research Institute, San Francisco, CA 94143, Department of Medicine, Vanderbilt University, Veterans Affairs Medical Centers, Nashville, TN 37232, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 and University of Miami School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA Corresponding author e-mail:
| | - Akila Mayeda
- Lawrence Berkeley National Laboratory, Life Sciences Division and
Department of Molecular and Cellular Biology, University of California at Berkeley, Berkeley, CA 94720, University of California, San Francisco, HHMI, Department of Medicine and Cardiovascular Research Institute, San Francisco, CA 94143, Department of Medicine, Vanderbilt University, Veterans Affairs Medical Centers, Nashville, TN 37232, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 and University of Miami School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA Corresponding author e-mail:
| | - John G. Conboy
- Lawrence Berkeley National Laboratory, Life Sciences Division and
Department of Molecular and Cellular Biology, University of California at Berkeley, Berkeley, CA 94720, University of California, San Francisco, HHMI, Department of Medicine and Cardiovascular Research Institute, San Francisco, CA 94143, Department of Medicine, Vanderbilt University, Veterans Affairs Medical Centers, Nashville, TN 37232, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 and University of Miami School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA Corresponding author e-mail:
| |
Collapse
|
3
|
Zhang Z, Kolls JK, Oliver P, Good D, Schwarzenberger PO, Joshi MS, Ponthier JL, Lancaster JR. Activation of tumor necrosis factor-alpha-converting enzyme-mediated ectodomain shedding by nitric oxide. J Biol Chem 2000; 275:15839-44. [PMID: 10747938 DOI: 10.1074/jbc.m000604200] [Citation(s) in RCA: 67] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Ectodomain shedding of cell surface proteins is an important process in a wide variety of physiological and developmental events. Recently, tumor necrosis factor-alpha-converting enzyme (TACE) has been found to play an essential role in the shedding of several critical surface proteins, which is evidenced by multiple developmental defects exhibited by TACE knockout mice. However, little is known about the physiological activation of TACE. Here, we show that nitric oxide (NO) activates TACE-mediated ectodomain shedding. Using an in vitro model of TACE activation, we show that NO activates TACE by nitrosation of the inhibitory motif of the TACE prodomain. Thus, NO production activates the release of cytokines, cytokine receptors, and adhesion molecules, and NO may be involved in other ectodomain shedding processes.
Collapse
Affiliation(s)
- Z Zhang
- Louisiana State University Health Sciences Gene Therapy Program, Louisiana State University School of Medicine, New Orleans, Louisiana 70112, USA
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Abstract
We describe a biphasic action of nitric oxide (NO) in its effects on oxidative killing of isolated cells: low concentrations protect against oxidative killing, while higher doses enhance killing, and these two effects occur by distinct mechanisms. While low doses of NO (from (Z)-1-[N-(3-ammonio propyl)-N-(n-propyl)-amino]-diazen-1-ium-1,2(2) diolate [PAPA/NO] or S-nitroso-N-acetyl-L-penicillamine [SNAP] prevent killing of rat hepatocytes by t-butylhydroperoxide (tBH), further increasing doses result in increased killing. Similar effects occur with rat hepatoma cells treated with PAPA/NO and tBH or H2O2. Increased killing with higher concentrations of NO donor is due to both NO and tBH, because NO donor alone is without effect. Glutathione (GSH) is not involved in either of these actions. Based on measurements of thiobarbituric acid-reactive substances (TBARS) and effects of lipid radical scavenger (DPPD) and deferoxamine, the protective effect, but not the enhancing effect, involves peroxidative chemistry. Fructose has no effect on tBH killing alone but provides substantial protection against killing by higher concentrations of NO plus tBH, suggesting that the enhancing effect involves mitochondrial dysfunction. Hepatocytes, when stimulated to produce NO endogenously, become resistant to tBH killing, indicative of the presence of an NO-triggered antioxidant defensive mechanism. The finding that the protective effects of low concentrations of NO and the harmful effects of high concentrations of NO are fundamentally different in nature suggest that therapeutic interventions could be designed, which selectively prevent its pro-oxidant activity at high concentrations, thus converting NO from a "Janus-faced" modulator of oxidant injury into a "pure" protectant.
Collapse
Affiliation(s)
- M S Joshi
- Department of Surgery, Louisiana State University Medical Center, New Orleans 70112, USA
| | | | | |
Collapse
|
5
|
Ponthier JL, Shackleton CH, Trant JM. Seasonal changes in the production of two novel and abundant ovarian steroids in the channel catfish (Ictalurus punctatus). Gen Comp Endocrinol 1998; 111:141-55. [PMID: 9679086 DOI: 10.1006/gcen.1998.7096] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Timely and appropriate changes in steroid plasma titers are necessary for successful reproduction in all vertebrates. Gonadal steroidogenesis of the most intensively cultured teleost species in North America, the channel catfish (Ictalurus punctatus), is poorly understood so a year-long study was conducted to investigate seasonal changes in ovarian steroidogenesis. Incubations of ovarian tissue were conducted monthly with [3H]pregnenolone and the medium was analyzed by high-performance liquid chromatography (HPLC) with radioactivity detection. The suite of steroids produced by the catfish ovary included the expected sex steroids (estradiol and testosterone) and 18 additional ovarian metabolites, including five steroids that have yet to be identified. Androstenedione, 20beta-dihydroprogesterone, 5|P-dihydrotestosterone, estriol, 11beta-hydroxyandrostenedione, 17-hydroxypregnenolone, 17-hydroxyprogesterone, 11beta-hydroxytestosterone, and progesterone were characterized by a combination of HPLC and thin-layer chromatography. Two of the most abundant steroids were isolated and analyzed by gas chromatography coupled with mass spectrometry (GC-MS). One of the steroids, 7alpha-hydroxypregnenolone (7P5), is a novel steroid in teleosts and was produced late in vitellogenic growth of the oocyte. Evidence suggests that the enzyme responsible for converting pregnenolone to 7P5, 7alpha-hydroxylase, is a cytochrome P450. The second abundant steroid metabolite was partially characterized by GC-MS as an hydroxylated form of 17-hydroxy-pregnenolone (chi,17P5). This steroid was most abundant when the ovary was regressed and during early vitellogenesis and rapidly decreased prior to spawning. In mammals, 7P5 has been identified as an important neurosteroid; however, the reproductive significance of 7P5 and chi,17P5 in catfish is unknown.
Collapse
Affiliation(s)
- J L Ponthier
- Department of Zoology and Physiology, Louisiana State University, Baton Rouge, Louisiana, 70803, USA
| | | | | |
Collapse
|